Related Experiment Video
Updated: May 10, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Recurrent or prolonged mechanical circulatory support: bridge to recovery or road to nowhere?
Yves d'Udekem1, Nobuaki Shime, Song Lou
1Department of Cardiac Surgery, Royal Children's Hospital, Melbourne, Australia. yves.dudekem@rch.org.au
Insights
For pediatric respiratory failure, extracorporeal membrane oxygenation (ECMO) offers prolonged support. However, for cardiac failure, ECMO beyond two weeks offers limited benefit, necessitating transition to ventricular assist devices or considering transplantation.
Area of Science:
- Pediatric Critical Care Medicine
- Cardiovascular Surgery
- Mechanical Circulatory Support
Background:
- Prolonged mechanical circulatory support (MCS) in children yields remarkable outcomes, yet futility thresholds remain unclear.
- Extracorporeal membrane oxygenation (ECMO) survival for pediatric respiratory failure declines with support duration.
- Cardiac failure management with MCS differs significantly from respiratory failure, with shorter effective support windows.
Purpose of the Study:
- To delineate the optimal duration of extracorporeal membrane oxygenation (ECMO) in pediatric patients with cardiac versus respiratory failure.
- To establish evidence-based guidelines for transitioning patients from ECMO to alternative mechanical circulatory support.
- To evaluate the efficacy and outcomes of repeat ECMO interventions in pediatric patients.
Main Methods:
- Review of clinical outcomes and survival data for pediatric patients undergoing prolonged mechanical circulatory support.
- Analysis of extracorporeal membrane oxygenation (ECMO) duration in relation to patient diagnosis (respiratory vs. cardiac failure).
- Evaluation of transition strategies to ventricular assist devices (VADs) and outcomes of repeat ECMO interventions.
Main Results:
- Extracorporeal membrane oxygenation (ECMO) can support pediatric respiratory failure for extended periods (weeks to months) if managed without complications.
- For pediatric cardiac failure, ECMO support beyond two weeks shows limited efficacy, with survival beyond 12 days in post-cardiac surgery patients being anecdotal.
- Repeat ECMO offers minimal long-term benefit unless organ transplantation is pursued; transition to VADs is recommended after two weeks without recovery.
Conclusions:
- Extracorporeal membrane oxygenation (ECMO) is viable for prolonged pediatric respiratory support but has a limited therapeutic window for cardiac failure.
- Transitioning pediatric cardiac failure patients to ventricular assist devices (VADs) after two weeks of ECMO is critical for improved outcomes.
- Repeat ECMO interventions in pediatric patients are generally not recommended due to poor long-term survival, except in the context of organ transplantation.
Abstract:
Remarkable outcomes have been reported after prolonged mechanical circulatory support in the pediatric population, but there is yet no clear delineation of the duration beyond which supporting a child becomes futile. The likelihood of survival in patients supported on extracorporeal membrane oxygenation for respiratory failure decreases with the length of support. However, extracorporeal membrane oxygenation can be successfully used in these patients for long periods (weeks to months) provided adequate support is maintained without complications. This is not the case with cardiac failure and mechanical circulatory support.Extracorporeal membrane oxygenation is usually the initial form of mechanical circulatory support used in patients with primary refractory myocardial dysfunction. There is evidence and consensus that if the patient shows no signs of recovery after a maximum duration of 2 weeks, he or she should be transitioned to a ventricular assist device, which allows prolonged support. In post-cardiac surgery patients, survival is only anecdotal beyond 12 days of extracorporeal membrane oxygenation support, and myocardial recovery is exceptionally rare after this time period unless new diagnoses and management strategies are formulated.Repeat extracorporeal membrane oxygenation should generally not be offered to patients unless it is established that support was withdrawn prematurely or a new intervention is planned. Repeat extracorporeal membrane oxygenation may achieve some improvement in early survival, but the long-term outcomes of survivors are so poor that these attempts cannot be generally recommended unless organ transplantation is an option.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Heart Failure VI: Adjunct Therapies
Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Restorative Care
Cardiomyopathy II: Dilated Cardiomyopathy

